Xometry CFO Miln James sells $814,491 in company stock

NORTH BETHESDA, MD—Miln James, Chief Financial Officer of Xometry , Inc. (NASDAQ:XMTR), a $1.25 billion market cap company, recently executed significant stock sales according to a Form 4 filing with the Securities and Exchange Commission. The transactions, completed to cover tax withholding obligations related to the vesting of restricted stock units, amounted to a total value of $814,491. According to InvestingPro data, the stock has seen a notable 35% gain over the past six months despite recent volatility.

On February 28, 2025, James sold 7,235 shares of Class A Common Stock at an average price of $26.6103 per share, totaling approximately $192,525. This sale was conducted automatically under a Rule 10b5-1 trading plan.

Subsequent transactions on March 4, 2025, involved the sale of 12,063 shares at an average price of $23.5413 and 13,789 shares at an average price of $24.5114. These sales collectively added up to $621,966.

Following these transactions, James retains direct ownership of 105,238 shares of Xometry, Inc. The sales were part of a pre-arranged trading plan and were executed to address tax obligations associated with performance-based restricted stock units. InvestingPro analysis shows the company maintains strong liquidity with a current ratio of 4.38, while operating with moderate debt levels. Discover more insights and 12 additional ProTips about XMTR’s financial health and market position with an InvestingPro subscription.

In other recent news, Xometry Inc. reported its fourth-quarter 2024 financial results, exceeding earnings expectations with an EPS of $0.06, compared to the forecasted $0.0267. The company’s revenue also surpassed projections, reaching $148.55 million against an expected $146.33 million, marking a 16% year-over-year growth. Craig-Hallum raised Xometry’s stock price target to $35, maintaining a Buy rating, despite softer first-quarter guidance due to lower gross margins. Goldman Sachs also increased its price target to $30, following Xometry’s robust earnings performance and positive guidance for fiscal year 2025. Cantor Fitzgerald, however, adjusted its price target to $20 while maintaining an Underweight rating, citing concerns over Xometry’s financial strategy and debt obligations. Analysts from different firms have highlighted Xometry’s potential for growth, with a focus on marketplace expansion and international sales. The company’s strategic initiatives, including AI enhancements and global sourcing, are seen as key factors in its future trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.